CWT

The headline -33.8% EPS decline to $2.15 looks alarming, but management's MD&A tells you not to read it that way: 2024 results were inflated by a ~$64M ($1.09/share) one-time cumulative benefit from the 2021 CA GRC booked retroactive to Jan 1, 2023. Strip that out and 2024 normalizes to ~$2.16, essentially flat versus 2025's $2.15. Underlying earnings are stable, not collapsing. The real engine kept working: revenue grew +6.4% to $964M on $69.6M of rate increases (partly offset by a $12.7M usage decline), operating cash flow rose +4% to $303M, and the dividend was hiked +12.8% to $73.9M — a payout near 58% of EPS, roughly a 2.5% yield. This is the classic regulated-utility profile: a price-regulated monopoly compounding its rate base (total assets +9.5% to $5.67B).

The quality, however, is only middling here and the price isn't cheap. Return on equity is just 7.6% — soft even for a regulated water name — and operating margin compressed to 17.7% as water-production, O&M and D&A costs (+$12.5M) outran rate relief. Long-term debt jumped +33% to $1.47B, lifting debt-to-equity to ~0.87 and pushing net interest expense up $9.1M, so the balance sheet is being levered into the capex cycle while returns lag. At 22.7x depressed-but-roughly-normalized EPS and 3.0x sales, the market is already paying a full defensive multiple for low-single-digit growth.